Fundz

Gaba Therapeutics reported raising $500,000 in an initial SEC Form D filing, from an offering of $1 Million

PRIVATEOct 10, 2023$500K of $1M raised

Amount Raised

$500,000

$500,000 sold, per SEC Form D (first sale Sep 26, 2023)

Round Type

Seed

Newport BeachHealthcare

Quick answer

GABA Therapeutics, Inc. raised $500,000 in a Seed round, dated September 26, 2023. GABA Therapeutics, Inc. is based in Newport Beach, California, United States.

How much did GABA Therapeutics, Inc. raise?
GABA Therapeutics, Inc. raised $500,000 in a Seed round on September 26, 2023.
What does GABA Therapeutics, Inc. do?
GABA Therapeutics is developing GRX-917 for anxiety and depression, with fast onset, minimal side effects and is non-addictive.
Where is GABA Therapeutics, Inc. based and how big is it?
GABA Therapeutics, Inc. is based in Newport Beach, California, United States.
Who are the decision-makers at GABA Therapeutics, Inc?
Fundz holds 1 contact at GABA Therapeutics, Inc., including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as GABA Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

Who to call at GABA Therapeutics, Inc., and when

A new round usually means GABA Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day GABA Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GABA Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GABA Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GABA Therapeutics, Inc.

Location

5000 BIRCH STREET, WEST TOWER,

Newport Beach, California, United States

About

GABA Therapeutics is developing GRX-917 for anxiety and depression, with fast onset, minimal side effects and is non-addictive. By naturally increasing neurosteroids, the drug could also benefit a broad range of other neuropsychiatric and neurological disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GABA Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRichard F., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for GABA Therapeutics, Inc.'s next move

See what Strategic adds

GABA Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.